These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 9722367

  • 1. Effective strategies in the management of Parkinson's disease.
    Wills AJ.
    Hosp Med; 1998 Apr; 59(4):287-90. PubMed ID: 9722367
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological therapy of complicated Parkinson's disease].
    Jiménez-Jiménez FJ, Molina JA.
    Rev Neurol; 1997 Aug; 25 Suppl 2():S170-9. PubMed ID: 9280685
    [Abstract] [Full Text] [Related]

  • 3. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T.
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Olanow CW, Obeso JA, Stocchi F.
    Nat Clin Pract Neurol; 2006 Jul; 2(7):382-92. PubMed ID: 16932589
    [Abstract] [Full Text] [Related]

  • 10. Levodopa in the early treatment of Parkinson's disease.
    Murata M.
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Parkinson's disease.
    Clarke C, Moore AP.
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract] [Full Text] [Related]

  • 13. Parkinson's disease.
    Clarke C, Moore A.
    Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
    [No Abstract] [Full Text] [Related]

  • 14. An approach to the continuous dopaminergic stimulation in Parkinson's disease.
    Schwartz M, Sabetay S.
    Isr Med Assoc J; 2012 Mar; 14(3):175-9. PubMed ID: 22675859
    [Abstract] [Full Text] [Related]

  • 15. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ.
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract] [Full Text] [Related]

  • 16. [Parkinson disease. Directed use of modern therapy].
    Möller JC, Wächter T, Oertel WH.
    MMW Fortschr Med; 2001 May 28; 143 Suppl 2():45-50. PubMed ID: 11434257
    [Abstract] [Full Text] [Related]

  • 17. Future therapies for Parkinson's disease.
    Hauser RA, Lyons KE.
    Neurol Clin; 2004 Oct 28; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of levodopa-induced motor complications.
    Stocchi F, Tagliati M, Olanow CW.
    Mov Disord; 2008 Oct 28; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [Abstract] [Full Text] [Related]

  • 19. [Current preclinical findings on substances against Parkinson's disease].
    Gerlach M, Riederer P.
    Nervenarzt; 2003 Mar 28; 74 Suppl 1():S2-6. PubMed ID: 12624677
    [Abstract] [Full Text] [Related]

  • 20. [The role of dopaminagonists in the treatment of Parkinson's disease].
    Ransmayr G.
    Praxis (Bern 1994); 2005 Oct 19; 94(42):1633-8. PubMed ID: 16277084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.